NI-0501

From Ganfyd

Jump to: navigation, search

NI-0501 is a human monoclonal antibody against interferon gamma, and is in Phase II testing to treat primary haemophagocytic lymphohistiocytosis (HLH). It is a member of the EMEA's PRIority MEdicines (PRIME) scheme for breakthrough therapies and has FDA break through therapy designation.

Personal tools